Provided by Tiger Trade Technology Pte. Ltd.

DEFIANCE DAILY TARGET 2X LONG HIMS ETF

25.03
+0.35001.42%
Pre-market: 25.530.5000+2.00%05:20 EDT
Volume:187.31K
Turnover:4.66M
Market Cap:58.06M
PE:- -
High:25.84
Open:24.74
Low:24.15
Close:24.68
52wk High:391.58
52wk Low:12.38
Shares:2.32M
Float Shares:2.32M
Volume Ratio:0.68
T/O Rate:8.08%
Dividend:1.98
Dividend Rate:7.91%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Can Hims & Hers (HIMS) Canadian GLP-1 Push Redefine Its Long-Term Profitability Playbook?

Simply Wall St.
·
May 27

Hims & Hers director David B. Wells reports purchase of 48,400 shares for $1.17 million

Reuters
·
May 27

Hims & Hers Health Is Maintained at Neutral by B of A Securities

Dow Jones
·
May 27

Moderately bullish activity in Hims and Hers Health with shares down 0.32%

TIPRANKS
·
May 27

BUZZ-BofA says Hims & Hers 2026 revenue target hinges on GLP-1 growth, lowers PT

Reuters
·
May 26

Does Medicine's New Obsession Really Work? -- Barrons.com

Dow Jones
·
May 26

BofA Adjusts Price Target on Hims & Hers Health to $25 From $28

MT Newswires Live
·
May 26

Hims & Hers : Bofa Global Research Cuts Price Objective to $25.00 From $28.00

THOMSON REUTERS
·
May 26

Does Medicine's New Obsession Really Work? -- Barron's

Dow Jones
·
May 23

Hims & Hers Health Is Maintained at Hold by Truist Securities

Dow Jones
·
May 22

Truist Adjusts Price Target on Hims & Hers Health to $23 From $18, Maintains Hold Rating

MT Newswires Live
·
May 22

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Hims & Hers Health (HIMS), AbCellera Biologics (ABCL) and Indivior (INDV)

TIPRANKS
·
May 22

YieldMax HIMS ETF Declares Weekly Dividend of $0.2186 Per Share

Deep News
·
May 22

Moderately bullish activity in Hims and Hers Health with shares up 3.78%

TIPRANKS
·
May 22

Sector Update: Healthcare Stocks Rise Thursday Afternoon

MT Newswires Live
·
May 22

Hims & Hers Health to Sell Generic GLP-1 Drugs in Canada

Dow Jones
·
May 21

Hims & Hers launches generic semaglutide access in Canada from CAD 149/month

Reuters
·
May 21

Hims & Hers: Introduces Access to Generic Semaglutide for Canadian Customers

THOMSON REUTERS
·
May 21

CORRECTED-Hims offers Apotex's generic semaglutide in Canada after Novo patent expiry

Reuters
·
May 21

Hims & Hers: IF Prescribed by a Licensed Healthcare Provider, Personalized Treatment Plans Start at C$149/Mo

THOMSON REUTERS
·
May 21